Villanueva Clarence Rachel, Barksdale Keane, Owolabi Tinuola, Bridges Donavan, Chichester Kristin, Saini Sarbjit, Oliver Eric T
Division of Allergy and Clinical Immunology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Front Allergy. 2024 Mar 27;5:1373511. doi: 10.3389/falgy.2024.1373511. eCollection 2024.
Mast cells are activated through a variety of different receptors to release preformed granules and mediators synthesized . However, the physiology and function of mast cells are not fully understood. Traditional studies of mast cell activation in humans have utilized cultures of tissue-derived mast cells including CD34+ progenitor cells or well-characterized commercially available cell lines. One limitation of these methods is that mast cells are no longer in a natural state. Therefore, their applicability to human skin disorders may be limited. Human skin explant models have been utilized to investigate the short-term effects of cell mediators, drugs, and irritants on skin while avoiding the ethical concerns surrounding stimulation studies with non-approved agents. Nonetheless, few studies have utilized intact human tissue to study mast cell degranulation. This "Methods" paper describes the development and application of an intact skin explant model to study human mast cell activation. In this manuscript, we share our protocol for setting up human skin explants and describe the results of stimulation experiments and techniques to minimize trauma-induced histamine release. Skin explants were generated using de-identified, full-thickness, non-diseased skin specimens from plastic and reconstructive surgeries. Results were reproducible and demonstrated FcɛRI- and MRGPRX2-induced mediator release which was inhibited with the use of a BTK inhibitor and QWF, respectively. Thus, this explant model provides a quick and accessible method of assessing human skin mast cell activation and inhibition.
肥大细胞通过多种不同受体被激活,从而释放预先形成的颗粒和合成的介质。然而,肥大细胞的生理学和功能尚未完全了解。传统上,对人类肥大细胞激活的研究利用了组织来源的肥大细胞培养物,包括CD34+祖细胞或特征明确的市售细胞系。这些方法的一个局限性在于肥大细胞不再处于自然状态。因此,它们对人类皮肤疾病的适用性可能有限。人类皮肤外植体模型已被用于研究细胞介质、药物和刺激物对皮肤的短期影响,同时避免了围绕未经批准的试剂进行刺激研究的伦理问题。尽管如此,很少有研究利用完整的人体组织来研究肥大细胞脱颗粒。这篇“方法”论文描述了一种用于研究人类肥大细胞激活的完整皮肤外植体模型的开发和应用。在本手稿中,我们分享了建立人类皮肤外植体的方案,并描述了刺激实验的结果以及将创伤诱导的组胺释放降至最低的技术。皮肤外植体是使用来自整形和重建手术的去识别化全层非病变皮肤标本生成的。结果具有可重复性,并证明了FcɛRI和MRGPRX2诱导的介质释放,分别使用BTK抑制剂和QWF可抑制这种释放。因此,这种外植体模型提供了一种快速且可及的评估人类皮肤肥大细胞激活和抑制的方法。